Carbenz 150 Injection belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.

Carbenz 150 Injection contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.

Carbenz 150 Injection is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of Carbenz 150 Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

To treat your condition effectually, continue taking Carbenz 150 Injection for as long as your doctor has prescribed. Do not stop the Carbenz 150 Injection midway. Talk to your doctor before taking Carbenz 150 Injection if you have severe allergic reactions to Carbenz 150 Injection or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Carbenz 150 Injection should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Carbenz 150 Injection if you are pregnant or breastfeeding because this Carbenz 150 Injection can cause harmful effects on the unborn baby. Both women and men using this Carbenz 150 Injection should use birth control to avoid pregnancy.

Carbenz 150 Injection contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.

Carbenz 150 Injection should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Carbenz 150 Injection. To treat your condition effectually, continue taking Carbenz 150 Injection for as long as your doctor has prescribed. Do not stop the Carbenz 150 Injection midway. Talk to your doctor before taking Carbenz 150 Injection if you have severe allergic reactions to Carbenz 150 Injection or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Carbenz 150 Injection should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Carbenz 150 Injection if you are pregnant or breastfeeding because this Carbenz 150 Injection can cause harmful effects on the unborn baby. Both women and men using this Carbenz 150 Injection should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during Carbenz 150 Injection treatment and appropriate until recovery is achieved.

• Peripheral blood counts should be frequently monitored during carboplatin treatment and, when appropriate, until recovery is achieved.
• Carbenz 150 Injection should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Carbenz 150 Injection.
• Your doctor may get routine blood tests done to monitor your liver function, electrolyte levels, and blood cell count in your blood.
• Avoid unnecessary or prolonged exposure to sunlight and UV light (such as tanning booths) and wear protective clothing, sunglasses, and sunscreen. Carbenz 150 Injection may make your skin sensitive to sunlight.